Alberto S Pappo

Summary

Affiliation: Baylor College of Medicine
Country: USA

Publications

  1. ncbi request reprint Two consecutive phase II window trials of irinotecan alone or in combination with vincristine for the treatment of metastatic rhabdomyosarcoma: the Children's Oncology Group
    Alberto S Pappo
    Texas Children s Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA
    J Clin Oncol 25:362-9. 2007
  2. ncbi request reprint Predictors of outcome in children and adolescents with rhabdomyosarcoma of the trunk--the St Jude Children's Research Hospital experience
    Chan Hon Chui
    Department of Pediatric Surgery, KK Women s and Children s Hospital, Singapore 229 899
    J Pediatr Surg 40:1691-5. 2005
  3. doi request reprint Pediatric gastrointestinal stromal tumors
    Alberto S Pappo
    Department of Pediatrics, Texas Children s Cancer Center, 6621 Fannin Street, CC1510 00, Houston, TX 77030, USA
    Hematol Oncol Clin North Am 23:15-34, vii. 2009
  4. doi request reprint Administration of high-dose interleukin-2 in a 2-year-old with metastatic melanoma
    M Brooke Bernhardt
    Department of Pharmacy, Texas Children s Hospital, Houston, Texas 77030, USA
    Pediatr Blood Cancer 53:1346-8. 2009
  5. ncbi request reprint Phase II trial of neoadjuvant vincristine, ifosfamide, and doxorubicin with granulocyte colony-stimulating factor support in children and adolescents with advanced-stage nonrhabdomyosarcomatous soft tissue sarcomas: a Pediatric Oncology Group Study
    Alberto S Pappo
    The Hospital for Sick Children, 555 University Ave, Toronto, ON, M5G1X8, Canada
    J Clin Oncol 23:4031-8. 2005
  6. ncbi request reprint Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk sarcomas: the St. Jude Children's Research Hospital experience
    Fariba Navid
    Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, Tennessee 38105 2794, USA
    Cancer 106:1846-56. 2006
  7. ncbi request reprint Treatment of Ewing sarcoma family of tumors: current status and outlook for the future
    Carlos Rodriguez-Galindo
    Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, Tennessee 38105, USA
    Med Pediatr Oncol 40:276-87. 2003
  8. ncbi request reprint Pooled analysis of phase II window studies in children with contemporary high-risk metastatic rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group
    Joanne J Lager
    Duke University Medical Center, Durham, NC 27710, USA
    J Clin Oncol 24:3415-22. 2006
  9. ncbi request reprint Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group
    Jane L Meza
    Department of Preventive and Societal Medicine, 984350 Nebraska Medical Center, Omaha, NE 68198 4350, USA
    J Clin Oncol 24:3844-51. 2006
  10. ncbi request reprint Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma--a report from the Intergroup Rhabdomyosarcoma Study IV
    John C Breneman
    Children s Hospital Medical Center, Division of Radiation Oncology, Cincinnati, OH 45219 0757, USA
    J Clin Oncol 21:78-84. 2003

Collaborators

Detail Information

Publications27

  1. ncbi request reprint Two consecutive phase II window trials of irinotecan alone or in combination with vincristine for the treatment of metastatic rhabdomyosarcoma: the Children's Oncology Group
    Alberto S Pappo
    Texas Children s Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA
    J Clin Oncol 25:362-9. 2007
    ....
  2. ncbi request reprint Predictors of outcome in children and adolescents with rhabdomyosarcoma of the trunk--the St Jude Children's Research Hospital experience
    Chan Hon Chui
    Department of Pediatric Surgery, KK Women s and Children s Hospital, Singapore 229 899
    J Pediatr Surg 40:1691-5. 2005
    ..The aim of this study was to determine predictors of outcome in childhood truncal rhabdomyosarcoma...
  3. doi request reprint Pediatric gastrointestinal stromal tumors
    Alberto S Pappo
    Department of Pediatrics, Texas Children s Cancer Center, 6621 Fannin Street, CC1510 00, Houston, TX 77030, USA
    Hematol Oncol Clin North Am 23:15-34, vii. 2009
    ..The generally accepted definition of pediatric GIST is a tumor that is diagnosed at the age of 18 years or younger. This review highlights the clinical features, molecular biology, and clinical management of this rare pediatric entity...
  4. doi request reprint Administration of high-dose interleukin-2 in a 2-year-old with metastatic melanoma
    M Brooke Bernhardt
    Department of Pharmacy, Texas Children s Hospital, Houston, Texas 77030, USA
    Pediatr Blood Cancer 53:1346-8. 2009
    ..This report describes our experience with the use of high-dose interleukin 2 (aldesleukin, IL-2) in a 2-year-old child with metastatic melanoma and describes our approach for the administration of this agent to young patients...
  5. ncbi request reprint Phase II trial of neoadjuvant vincristine, ifosfamide, and doxorubicin with granulocyte colony-stimulating factor support in children and adolescents with advanced-stage nonrhabdomyosarcomatous soft tissue sarcomas: a Pediatric Oncology Group Study
    Alberto S Pappo
    The Hospital for Sick Children, 555 University Ave, Toronto, ON, M5G1X8, Canada
    J Clin Oncol 23:4031-8. 2005
    ..To describe the response rate and survival of children and adolescents with unresected or metastatic nonrhabdomyosarcomatous soft tissue sarcomas (NRSTS) treated with vincristine, ifosfamide, and doxorubicin...
  6. ncbi request reprint Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk sarcomas: the St. Jude Children's Research Hospital experience
    Fariba Navid
    Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, Tennessee 38105 2794, USA
    Cancer 106:1846-56. 2006
    ..Vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide are highly effective against pediatric sarcomas. The authors investigated the feasibility of administering these agents concomitantly within a defined period...
  7. ncbi request reprint Treatment of Ewing sarcoma family of tumors: current status and outlook for the future
    Carlos Rodriguez-Galindo
    Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, Tennessee 38105, USA
    Med Pediatr Oncol 40:276-87. 2003
    ..Our current understanding in the biology and treatment of ESFT suggests that a more rational approach to the development of risk-adapted therapy should be undertaken...
  8. ncbi request reprint Pooled analysis of phase II window studies in children with contemporary high-risk metastatic rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group
    Joanne J Lager
    Duke University Medical Center, Durham, NC 27710, USA
    J Clin Oncol 24:3415-22. 2006
    ..The Soft Tissue Sarcoma Committee of the Children's Oncology Group has conducted five upfront window trials in patients with newly diagnosed metastatic rhabdomyosarcoma to identify promising new treatment agents...
  9. ncbi request reprint Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group
    Jane L Meza
    Department of Preventive and Societal Medicine, 984350 Nebraska Medical Center, Omaha, NE 68198 4350, USA
    J Clin Oncol 24:3844-51. 2006
    ..The outcome for localized rhabdomyosarcoma (RMS) or undifferentiated sarcoma (UDS) is affected by age, histology, primary anatomic site, extent of disease, and therapy...
  10. ncbi request reprint Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma--a report from the Intergroup Rhabdomyosarcoma Study IV
    John C Breneman
    Children s Hospital Medical Center, Division of Radiation Oncology, Cincinnati, OH 45219 0757, USA
    J Clin Oncol 21:78-84. 2003
    ..To identify risk factors associated with outcomes in children with metastatic rhabdomyosarcoma (RMS) treated on the fourth Intergroup Rhabdomyosarcoma Study (IRS-IV)...
  11. ncbi request reprint New drugs for the treatment of metastatic or refractory soft tissue sarcomas in children
    Abha A Gupta
    Hospital for Sick Children, Division of Hematology Oncology, Toronto, Canada
    Future Oncol 2:675-85. 2006
    ..The progress to date and the tools used in the treatment of advanced pediatric sarcomas will be summarized in this review...
  12. ncbi request reprint Reducing irinotecan-associated diarrhea in children
    Lars M Wagner
    Division of Pediatric Hematology Oncology, Cincinnati Children s Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA
    Pediatr Blood Cancer 50:201-7. 2008
    ..This approach is feasible in children and allows for tolerance of higher doses of protracted irinotecan...
  13. ncbi request reprint Preradiation chemotherapy with methotrexate, cisplatin, 5-fluorouracil, and leucovorin for pediatric nasopharyngeal carcinoma
    Carlos Rodriguez-Galindo
    Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, Tennessee 38105, USA
    Cancer 103:850-7. 2005
    ..Chemotherapy may help to decrease the radiotherapy dose and limit the side effects of local therapies. However, little is known regarding the chemosensitivity of NPC tumors in pediatric patients...
  14. ncbi request reprint Remote intrapulmonary spread of recurrent respiratory papillomatosis with malignant transformation
    Sherri L Katz
    Department of Pediatrics, Hospital for Sick Children, Toronto, Ontario, Canada
    Pediatr Pulmonol 39:185-8. 2005
    ..Treatment options for intrapulmonary spread have shown limited success. We describe a case of recurrent respiratory papillomatosis with extensive parenchymal involvement and adenosquamous carcinoma in a 14-year-old girl...
  15. ncbi request reprint Late events occurring five years or more after successful therapy for childhood rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group
    Lillian Sung
    The Division of Hematology Oncology, Hospital for Sick Children, 555 University Avenue, Toronto, Ont, M5G 1X8, Canada
    Eur J Cancer 40:1878-85. 2004
    ..Late events after successful treatment for rhabdomyosarcoma occur in 9%. Those with advanced disease and large primary tumours have the highest risk of late events...
  16. ncbi request reprint Brain metastases of malignant germ cell tumors in children and adolescents
    Sheri L Spunt
    Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, Tennessee 38105, USA
    Cancer 101:620-6. 2004
    ..Brain metastases of pediatric germ cell tumors are uncommon, and there is limited information regarding their incidence, clinical presentation, response to treatment, and influence on survival...
  17. ncbi request reprint Perianal rhabdomyosarcoma presenting as a perirectal abscess: A report of 11 cases
    D Ashley Hill
    Department of Pathology, St Jude Children s Research Hospital and University of Tennessee, Memphis TN, USA
    J Pediatr Surg 37:576-81. 2002
    ....
  18. ncbi request reprint C-kit expression in pediatric solid tumors: a comparative immunohistochemical study
    Brandon E Smithey
    Department of Pathology, University of Tennessee Medical Center, Memphis, Tennessee, USA
    Am J Surg Pathol 26:486-92. 2002
    ..Tumors with strong, diffuse staining for c-kit in a pattern similar to gastrointestinal stromal tumor may represent suitable targets for new therapeutic agents...
  19. ncbi request reprint Treatment of refractory osteosarcoma with fractionated cyclophosphamide and etoposide
    Carlos Rodriguez-Galindo
    Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, Tennessee 38105 2794, USA
    J Pediatr Hematol Oncol 24:250-5. 2002
    ..By identifying new chemotherapeutic strategies, the outcome of these patients can be improved and the toxicity of treatment regimens decreased...
  20. ncbi request reprint Clinical features and outcome of initially unresected nonmetastatic pediatric nonrhabdomyosarcoma soft tissue sarcoma
    Sheri L Spunt
    Department of Hematology Oncology, St Jude Children s Research Hospital, University of Tennessee College of Medicine, 332 N Lauderdale Street, Memphis, TN 38105 2794, USA
    J Clin Oncol 20:3225-35. 2002
    ..To describe the clinical features, response to therapy, and outcome of pediatric patients with initially unresected nonmetastatic nonrhabdomyosarcoma soft tissue sarcoma (NRSTS)...
  21. ncbi request reprint A chemosensitive pediatric extraosseous osteosarcoma: case report and review of the literature
    Karen Wodowski
    Departments of Hematology Oncology, St Jude s Research Hospital, 332 N Lauderdale Street, Memphis, TN 38105 2794, USA
    J Pediatr Hematol Oncol 25:73-7. 2003
    ..Children with extraosseous osteosarcoma may have a more favorable response to treatment than adults; thus, a curative approach using combined modality therapy appears warranted...
  22. ncbi request reprint Treatment of localized nonorbital, nonparameningeal head and neck rhabdomyosarcoma: lessons learned from intergroup rhabdomyosarcoma studies III and IV
    Alberto S Pappo
    Department of Pediatrics, Hospital for Sick Children, Toronto, Ontario, Canada
    J Clin Oncol 21:638-45. 2003
    ..The characteristics and clinical outcomes of children and adolescents with localized nonorbital, nonparameningeal head and neck rhabdomyosarcoma (RMS) treated on national protocols from the Intergroup Rhabdomyosarcoma Group are reported...
  23. ncbi request reprint Malignant fibrous histiocytoma and other fibrohistiocytic tumors in pediatric patients: the St. Jude Children's Research Hospital experience
    Najat C Daw
    Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, Tennessee 38105, USA
    Cancer 97:2839-47. 2003
    ..In the current study, the authors reviewed their institutional experience with these tumors to characterize their clinical features in pediatric patients and assess the impact of surgical resection on outcome...
  24. ncbi request reprint Orbital inflammatory syndromes with systemic involvement may mimic metastatic disease
    Melanie R Foley
    Department of Ophthalmology, University of Tennessee Health Science Center, Memphis, Tennessee, USA
    Ophthal Plast Reconstr Surg 19:324-7. 2003
    ..Accurate diagnosis requires careful clinical and pathologic examinations...
  25. ncbi request reprint Metastatic rhabdomyosarcoma: a retrospective review of patients treated at the hospital for sick children between 1989 and 1999
    Brent A Williams
    Division of Hematology Oncology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Canada
    J Pediatr Hematol Oncol 26:243-7. 2004
    ....
  26. ncbi request reprint Neurofibromatosis in children with Rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma study IV
    Lillian Sung
    Division of Hematology Oncology, Hospital for Sick Children, Toronto, Ontario, Canada
    J Pediatr 144:666-8. 2004
    ..Among 1025 eligible patients, 5 (0.5 %) had NF1. Three children had relapses, two of whom died of progressive disease. Patients with NF1 and rhabdomyosarcoma should be treated with intensive contemporary therapy protocols...
  27. ncbi request reprint Survival after recurrence of Ewing tumors: the St Jude Children's Research Hospital experience, 1979-1999
    Carlos Rodriguez-Galindo
    Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, Tennessee 38105, USA
    Cancer 94:561-9. 2002
    ..Despite improved therapies, 30-40% of patients with Ewing tumors (ET) experience recurrence and have a poor prognosis. The authors analyzed factors prognostic of survival in patients with recurrent ET...